selected scholarly activity
-
conferences
- Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.. Journal of Clinical Oncology. 308-317. 2025
- IMPACT OF THE ROCCO STITCH ON RETURN TO CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL. Journal of Urology. E569-E570. 2018
- Pathologist Call Rate Variation in 892 Prostatectomies Assessed Using Funnel Plots. Modern Pathology. 330-330. 2018
- High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.. Journal of Clinical Oncology. 248-257. 2018
- MP53-03 IMPACT OF LOWER CASTRATE-LEVEL TESTOSTERONE ON PROGRESSION TO CASTRATE-RESISTANT PROSTATE CANCER FOR PATIENTS UNDERGOING CONTINUOUS ANDROGEN DEPRIVATION THERAPY: A PROSPECTIVE COHORT STUDY. Investigative Urology. E713-E714. 2017
- LB-S&T-32 CHARACTERIZING THE ROLE OF ANTI-GRP78 AUTOANTIBODIES IN PROSTATE CANCER PROGRESSION. Investigative Urology. E350-E350. 2016
- MP20-09 ROBOTIC SURGICAL SKILL ACQUISITION IN TRAINEES: A RANDOMIZED COMPARISON OF THE TWO ROBOTIC TRAINERS AND TRAINEES’ SKILLS TRANSFER TO A 3-D PRINTED SIMULATED SURGICAL TASK IN THE OPERATING ROOM. Investigative Urology. E215-E216. 2016
- MP80-08 IMPACT OF POSTERIOR URETHROVESICAL RECONSTRUCTION ON EARLY RETURN TO CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RANDOMIZED CONTROLLED TRIAL. Investigative Urology. E1046-E1046. 2016
- Effect of anti-GRP78 autoantibodies on prostate cancer progression through tissue factor procoagulant activity.. Journal of Clinical Oncology. 258-258. 2016
- Contribution of Anti-GRP78 autoantibodies to prostate cancer progression through tissue factor procoagulant activity. BJU International. 85-86. 2015
- MP17-14 UTILITY OF PREOPERATIVE 3 TESLA MULTIPARAMETRIC PELVIC PHASED-ARRAY MAGNETIC RESONANCE IMAGING IN PREDICTION OF EXTRACAPSULAR EXTENSION OF PROSTATE CANCER AND ITS IMPACT ON SURGICAL MARGIN STATUS: EXPERIENCE AT A CANADIAN TERTIARY ACADEMIC HEALTH CENTER. Investigative Urology. E181-E181. 2015
- MP57-20 VARIANT HISTOLOGY DOES NOT PREDICT SURVIVAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: RESULTS FROM THE CANADIAN UPPER TRACT COLLABORATION. Investigative Urology. E697-E697. 2015
- PD25-10 RESIDENT INVOLVEMENT IN ENDOSCOPIC BLADDER CANCER SURGERY IS ASSOCIATED WITH INADEQUATE PATHOLOGY SPECIMENS AND PROLONGED TIME TO CYSTECTOMY. Investigative Urology. E564-E564. 2015
- Adjuvant Radiation, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of RTOG 0621. International Journal of Radiation Oncology Biology Physics. S2-S2. 2014
- Adjuvant radiation, androgen deprivation, and docetaxel for high-risk prostate cancer post-prostatectomy: Results of RTOG 0621.. Journal of Clinical Oncology. 5031-5031. 2014
- VALIDATION OF AN INTRAOPERATIVE ASSESSMENT TOOL FOR EVALUATING TRAINEES AND PROVIDING FEEDBACK DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY. Investigative Urology. E168-E168. 2014
- Transurethral (TURP) biopsy of suspected anterior prostate cancers identified by MRI: Pilot study of a novel technique.. Journal of Clinical Oncology. 230-230. 2014
- 1440 EMERGENCE OF VARIANT HISTOLOGY DURING NEO-ADJUVANT CHEMO-THERAPY FOR MUSCLE INVASIVE URETHELIAL BLADDER CANCER IS COMMON AND ASSOCIATED WITH POOR PROGNOSIS. Investigative Urology. E590-E590. 2013
- 1441 INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY. Investigative Urology. E590-E591. 2013
- 1563 TOWARDS DEVELOPMENT AND VALIDATION OF AN INTRAOPERATIVE OBJECTIVE ASSESSMENT TOOL FOR TRAINEE EVALUATION OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: RESULTS OF A DELPHI STUDY TO CREATE AN INVENTORY OF PROCEDURAL STEPS. Investigative Urology. E641-E642. 2013
- Testosterone suppression: Impact of testosterone level on disease progression in advanced prostate cancer.. Journal of Clinical Oncology. 46-46. 2012
- 1448 IS THERE A ROLE FOR ROUTINE ANTERIOR ZONE SAMPLING DURING TRANSRECTAL ULTRASOUND GUIDED SATURATION PROSTATE BIOPSY?. Investigative Urology. e587-e587. 2012
- Is There a Role for Routine Anterior Zone Sampling During Transrectal Ultrasound Guided Saturation Prostate Biopsy?. Urology. S134-S135. 2012
- 1491 DESIGNING A HIGH-FIDELITY LAPAROSCOPIC PARTIAL NEPHRECTOMY BENCH MODEL: DETERMINING THE TEAR STRENGTH AND RESISTANCE OF A SYNTHETIC SILICONE COMPOSITION. Investigative Urology. E597-E598. 2011
- 1633 HIGH INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: IMPACT OF NADIR PSA ON CANCER CONTROL. Investigative Urology. E655-E655. 2011
- 587 ANTERIOR PROSTATE BIOPSIES REVEAL A SANCTUARY SITE OF PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE EXTENDED PROSTATE BIOPSIES. European Urology Open Science. 198-198. 2010
- Laparoscopic repair of an inferior vena cava injury during a right partial nephrectomy. Journal of Endourology. A323-A323. 2006
- The anterior layer of Denonvilliers' fascia: A common misconception in the laparoscopic prostatectomy literature.. Journal of Endourology. A224-A224. 2006
- Predicting recurrence following post-chemotherapy retroperitoneal lymph node dissection for residual fibrosis or teratoma.. Journal of Clinical Oncology. 229S-229S. 2006
- 157: The Vesicoprostatic Muscle: A Critical Landmark During Dissection of the Posterior Bladder Neck in Laparoscopic Radical Prostatectomy. Investigative Urology. 51-51. 2006
- 449: The Impact of Residual Extra-Retroperitoneal Masses in Patients with Advanced Non-Seminomatous Germ Cell Testicular Cancer. Investigative Urology. 145-146. 2006
- 593: The Incidence and Implications of Disease Outside a Modified Template in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) for Metastatic Non-Seminomatous Germ Cell Tumors (NSGCT). Investigative Urology. 192-192. 2006
- 967: The Anatomic and Pathologic Characteristics of Irradiated Prostate Cancers May Influence the Oncologic Efficacy of Salvage Therapies. Investigative Urology. 312-312. 2006
- V1219: Laparoscopic Repair of an Inferior Vena Cava Injury during a Right Partial Nephrectomy. Investigative Urology. 392-393. 2006
- 272: Cancer Characteristics and Cancer Control in Men with PSA of 4 Ngzml or Less Treated with Radical Prostatectomy (RP). Investigative Urology. 75-75. 2005
- 428: Clinical Outcome of Intermediate- and Poor-Risk Patients with Non-Seminomatous Germ Cell Testicular Cancer (NSGCT) Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND). Investigative Urology. 117-117. 2005
- Human sperm DNA denaturation and seminal antioxidant activity in fertile and infertile men. Journal of Urology. 313-313. 2002
- Isolated abnormality of sperm DNA integrity in male infertility is uncommon. Journal of Urology. 350-351. 2002
-
journal articles
- 2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update).. Journal of the Canadian Urological Association. 19:E142-E152. 2025
- The far-reaching impact of robotic-assisted surgery on healthcare systems.. Healthcare Management Forum. 38:156-165. 2025
- Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta-analysis.. BJU International. 135:380-389. 2025
- Association of marginalization and PSMA-PET in prostate cancer: An analysis of the Ontario PSMA-PET Registry for Recurrent Prostate Cancer.. Journal of the Canadian Urological Association. 19:193-201. 2025
- Melatonin for preventing postoperative delirium in elderly patients: A multicenter randomized placebo-controlled pilot study.. Medicine (United States). 104:e41615. 2025
- Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer.. International Journal of Radiation Oncology Biology Physics. 121:317-324. 2025
- Patterns of failure with 18F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysis.. Journal of the Canadian Urological Association. 19:17-24. 2025
- 2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.. Journal of the Canadian Urological Association. 19:E1-E16. 2025
- A Case Report: PSMA PET/CT in Retroperitoneal Hemangioma.. Clinical Nuclear Medicine. 50:e43-e46. 2025
- Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines.. Cancer. 131:e35606. 2025
- Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.. Journal of the Canadian Urological Association. 19:E25-E35. 2025
- Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial.. JAMA Surgery. 159:1355-1363. 2024
- The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer. Investigative Urology. 212:710-719. 2024
- The Safety and Feasibility of Ambulatory Minimally Invasive Partial Nephrectomy: A Systematic Review and Meta-Analysis.. Journal of Endourology. 38:1112-1120. 2024
- Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.. JACC: CardioOncology. 6:761-771. 2024
- Predictors of failed same-day discharge in patients undergoing robot-assisted radical prostatectomy in a Canadian universal healthcare system. Journal of the Canadian Urological Association. 18:316-320. 2024
- Hospital volume-outcome relationships for robot-assisted surgeries: a population-based analysis. Surgical Endoscopy. 38:4531-4542. 2024
- Small Molecules Targeting GRP78 Mitigate Anti- GRP78 Autoantibody-Mediated Tissue Factor Procoagulant Activity in Cultured Endothelial Cells. Journal of Thrombosis and Haemostasis. 22:3290-3304. 2024
- 2024 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium. Journal of the Canadian Urological Association. 18:E179-86. 2024
- Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of Clinical Oncology. 42:1222-1228. 2024
- Hospital learning curves for robot-assisted surgeries: a population-based analysis. Surgical Endoscopy. 38:1367-1378. 2024
- Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patient’s post-surgical resection. Journal of the Canadian Urological Association. 18:E53-E58. 2024
- Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis. European urology oncology. 7:1350-1357. 2024
- Images in urology – Metastatic urothelial carcinoma of the right vastus lateralis following robotic-assisted radical cystectomy. Journal of the Canadian Urological Association. 18:E37-E39. 2024
- A systematic review of full economic evaluations of robotic-assisted surgery in thoracic and abdominopelvic procedures. Journal of Robotic Surgery. 17:2671-2685. 2023
- Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers. European urology oncology. 6:597-603. 2023
- 2023 Canadian Urological Association guideline: Genetic testing in prostate cancer. Journal of the Canadian Urological Association. 17:314-25. 2023
- Genetic testing practices among specialist physicians who treat prostate cancer. Journal of the Canadian Urological Association. 17:326-336. 2023
- Minimizing the learning curve for robotic-assisted radical cystectomy. Journal of the Canadian Urological Association. 17:E252-E256. 2023
- Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada. Prostate Cancer and Prostatic Diseases. 26:74-79. 2023
- The evolving use of robotic surgery: a population-based analysis. Surgical Endoscopy. 37:1870-1877. 2023
- First Canadian experience with same-day discharge after robot-assisted radical prostatectomy. Journal of the Canadian Urological Association. 17:39-43. 2023
- The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer. JACC: CardioOncology. 5:70-81. 2023
- Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index Threshold. Investigative Urology. 209:111-120. 2023
- Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada. Journal of Medical Economics. 25:583-590. 2022
- UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer. Journal of the Canadian Urological Association. 16:E581-E589. 2022
- 2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). Journal of the Canadian Urological Association. 16:E506-15. 2022
- Robotic thoracic surgery in Canada: Are patients willing to pay out of pocket?. Canadian Journal of Surgery. 65:E683-E687. 2022
- Patterns of care for non‐metastatic castration‐resistant prostate cancer: A population‐based study. BJUI Compass. 3:383-391. 2022
- UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text). Journal of the Canadian Urological Association. 16:E416-31. 2022
- Adverse events following robotic surgery: population-based analysis. British Journal of Surgery. 109:763-771. 2022
- Successful Same-Day Discharge for Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis. Urology Practice. 9:294-305. 2022
- Scratching the Surface—An Overview of the Roles of Cell Surface GRP78 in Cancer. Biomedicines. 10:1098-1098. 2022
- Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy. Investigative Urology. 207:1020-1028. 2022
- Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada. Urologic Oncology: Seminars and Original Investigations. 40:192.e1-192.e9. 2022
- Extraperitoneal versus transperitoneal approach for robot-assisted radical prostatectomy: a contemporary systematic review and meta-analysis. Journal of Robotic Surgery. 16:257-264. 2022
- Canadian Urological Association guideline: Management of small renal masses – Full-text. Journal of the Canadian Urological Association. 16:E61-75. 2022
- Canadian Urological Association guideline: Management of small renal masses – Summary of recommendations. Journal of the Canadian Urological Association. 16:24-5. 2022
- Development and initial validation of a cost-effective, re-usable, ultrasound-compatible suprapubic catheter insertion training simulator. Journal of the Canadian Urological Association. 16:63-69. 2022
- Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A call to action. Journal of the Canadian Urological Association. 16:15-15. 2022
- Visceral adipose tissue loss and 24-hour urinary profile changes post-bariatric surgery.. Canadian Journal of Urology. 29:11005-11011. 2022
- Canadian Urologic Association best practice report: Bone health in prostate cancer. Journal of the Canadian Urological Association. 15:375-382. 2021
- Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer. JNCI Cancer Spectrum. 5. 2021
- Development and Comparability of a Short Food-Frequency Questionnaire to Assess Diet in Prostate Cancer Patients: The Role of Androgen Deprivation Therapy in CArdiovascular Disease – A Longitudinal Prostate Cancer Study (RADICAL PC) Substudy. Current Developments in Nutrition. 5:nzab106-nzab106. 2021
- Canadian consensus forum of key controversial areas in the management of advanced prostate cancer. Journal of the Canadian Urological Association. 15:353-358. 2021
- Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer. Journal of the Canadian Urological Association. 15:E424-E460. 2021
- Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version. Journal of the Canadian Urological Association. 15:230-9. 2021
- Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada. Cancers. 13:2844-2844. 2021
- Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies. Journal of the Canadian Urological Association. 15:E307-E322. 2021
- Message from the CUA 2021 Scientific Committee. Journal of the Canadian Urological Association. 15:S46-7. 2021
- Psychological morbidity associated with prostate cancer: Rates and predictors of depression in the RADICAL PC study. Journal of the Canadian Urological Association. 15:181-186. 2021
- Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy. Obesity Surgery. 31:1673-1679. 2021
- Development, implementation, and evaluation of a competency-based didactic and simulation-focused boot camp for incoming urology residents: Report of the first three years. Journal of the Canadian Urological Association. 15:98-105. 2021
- 2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC) (full-text). Journal of the Canadian Urological Association. 15:E81-9. 2021
- Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. Journal of the Canadian Urological Association. 15:E90-E96. 2021
- Canadian Urological Association Best Practice Report: Holmium: YAG laser eye safety. Journal of the Canadian Urological Association. 14:380-382. 2020
- Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Journal of the Canadian Urological Association. 14:E616-E620. 2020
- Economic evaluation of robot-assisted radical prostatectomy compared to open radical prostatectomy for prostate cancer treatment in Ontario, Canada. Journal of the Canadian Urological Association. 14:E350-E357. 2020
- A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association. Journal of the Canadian Urological Association. 14:163-168. 2020
- Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study. Investigative Urology. 203:1109-1116. 2020
- Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 14:123-130. 2020
- A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy. Journal of the Canadian Urological Association. 14:130-138. 2020
- Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum. Journal of the Canadian Urological Association. 14:E137-E149. 2020
- Immunohistochemistry Use by Diagnostic Category and Pathologist in 4477 Prostate Core Biopsy Sets Assessed at Two Hospitals. Applied Immunohistochemistry and Molecular Morphology. 28:259-266. 2020
- Continuing towards optimization of bladder cancer care in Canada: Summary of the 3rd Bladder Cancer Canada-Canadian Urological Association- Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting. Journal of the Canadian Urological Association. 14:E115-E125. 2020
- Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer. Journal of the Canadian Urological Association. 14:17-23. 2020
- Complex Surgery and Perioperative Systemic Therapy for Genitourinary Cancer of the Retroperitoneum. Current Oncology. 27:34-42. 2020
- Management algorithms for metastatic prostate cancer. Journal of the Canadian Urological Association. 13:50-60. 2020
- Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy. Investigative Urology. 202:1001-1007. 2019
- Canadian Urological Association guideline: Muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 13:230-238. 2019
- 2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC). Journal of the Canadian Urological Association. 13:307-314. 2019
- Canadian Urological Association guideline on perioperative thromboprophylaxis and management of anticoagulation. Journal of the Canadian Urological Association. 13:105-114. 2019
- Patient presentation, differential diagnosis, and management of penile lesions.. Journal of the Canadian Urological Association. 13:S2-S8. 2019
- Use of machine learning to predict early biochemical recurrence after robot‐assisted prostatectomy. BJU International. 123:51-57. 2019
- Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. JCI insight. 3:99363. 2018
- Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report. Journal of Medical Case Reports. 12:373. 2018
- Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces. Journal of the Canadian Urological Association. 12:328-336. 2018
- Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells. Prostate. 78:953-961. 2018
- Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association- Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting. Journal of the Canadian Urological Association. 12:E281-97. 2018
- Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Journal of the Canadian Urological Association. 12:173-80. 2018
- The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation. British Journal of Cancer. 118:1399-1405. 2018
- Compliance of the recurrent renal stone former with current best practice guidelines. Journal of the Canadian Urological Association. 12:E112-20. 2018
- Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer – A Canadian consensus statement. Journal of the Canadian Urological Association. 12:E45-6. 2018
- Testosterone suppression in the treatment of recurrent or metastatic prostate cancer — A Canadian consensus statement. Journal of the Canadian Urological Association. 12:30-7. 2018
- A Randomized Comparison of 2 Robotic Virtual Reality Simulators and Evaluation of Trainees' Skills Transfer to a Simulated Robotic Urethrovesical Anastomosis Task. Urology. 111:110-115. 2018
- Images in urology: Localized primary amyloidosis of the urinary bladder. Journal of the Canadian Urological Association. 12:E42-4. 2018
- Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor. Journal of Biological Chemistry. 292:21180-21192. 2017
- Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression. Neoplasia. 19:857-867. 2017
- Positive surgical margin rates during the robot-assisted laparoscopic radical prostatectomy learning curve of an experienced laparoscopic surgeon. Journal of the Canadian Urological Association. 11:E409-13. 2017
- Towards development and validation of an intraoperative assessment tool for robot-assisted radical prostatectomy training: results of a Delphi study. International Braz J Urol: official journal of the Brazilian Society of Urology. 43:661-670. 2017
- Adjuvant radiation therapy, androgen deprivation, and docetaxel for high‐risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 123:2489-2496. 2017
- Case: Spontaneous regression of post-radical prostatectomy prostate-specific antigen elevation without adjuvant therapy in a patient with lymph node metastasis. Journal of the Canadian Urological Association. 11:E315-7. 2017
- Quality indicators in the management of bladder cancer: A modified Delphi study. Urologic Oncology: Seminars and Original Investigations. 35:328-334. 2017
- Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians. Journal of the Canadian Urological Association. 11:204-204. 2017
- Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate cancer and its impact on surgical margin status: Experience at a Canadian academic tertiary care centre. Journal of the Canadian Urological Association. 11:174-174. 2017
- Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 35:668-680. 2017
- Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer. Journal of Xiangya Medicine. 2:17-17. 2017
- Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. Investigative Urology. 196:1627-1633. 2016
- Prostate cancer, ESMO 2016. Journal of the Canadian Urological Association. 10:S231-S234. 2016
- How I do it: Prescribing abiraterone acetate for metastatic castration resistant prostate cancer.. Canadian Journal of Urology. 23:8388-8394. 2016
- Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes. Scandinavian Journal of Urology. 50:234-238. 2016
- Author Reply. Urology. 91:135-135. 2016
- Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique. Urology. 91:129-135. 2016
- Complete resection of a primitive neuroectodermal tumour arising in the bladder of a 31-year-old female after neoadjuvant chemotherapy. Journal of the Canadian Urological Association. 10:264-264. 2016
- Contemporary agents in the management of metastatic castration-resistant prostate cancer. Journal of the Canadian Urological Association. 10:414-414. 2016
- Mitigating pelvic recurrence and improving overall survival. Journal of the Canadian Urological Association. 10:95-95. 2016
- Prostate cancer, ESMO 2016. Journal of the Canadian Urological Association. 10:331-331. 2016
- Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015. Journal of the Canadian Urological Association. 10:46-46. 2016
- Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study. Urology. 86:1174-1178. 2015
- Pure laparoscopic unilateral nephrectomy for a patient with a polycystic horseshoe kidney. Journal of the Canadian Urological Association. 8:881-881. 2014
- The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. Journal of the Canadian Urological Association. 8:845-845. 2014
- Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy. Urologic Oncology: Seminars and Original Investigations. 32:975-980. 2014
- Current management of advanced and castration resistant prostate cancer.. Canadian Journal of Urology. 21:1-6. 2014
- Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice.. Canadian Journal of Urology. 21:28-36. 2014
- Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus. Urology. 83:812-817. 2014
- Academic transplant urologist. Journal of the Canadian Urological Association. 8. 2014
- Is there a role for anterior zone sampling as part of saturation trans-rectal ultrasound guided prostate biopsy?. BMC Urology. 14:34-34. 2014
- Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis. Annals of Surgical Oncology. 20:3675-3684. 2013
- Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease. Journal of the Canadian Urological Association. 7:108-13. 2013
- Defining a new testosterone threshold for medical castration: Results from a prospective cohort series. Journal of the Canadian Urological Association. 7:263-263. 2013
- Left behind: The potential problem of residual cancer. Journal of the Canadian Urological Association. 7:39-39. 2013
- PSA implications and medical management of prostate cancer for the primary care physician.. Canadian Journal of Urology. 19 Suppl 1:28-35. 2012
- Single‐session primary high‐intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation‐based technology. BJU International. 110:1142-1148. 2012
- Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site. Urology. 79:1079-1084. 2012
- Urothelial carcinoma involving the distal penis. Journal of the Canadian Urological Association. 6:81-83. 2012
- Clinical Impact of Residual Extraretroperitoneal Masses in Patients With Advanced Nonseminomatous Germ Cell Testicular Cancer. Urology. 79:156-159. 2012
- Surgery for prostate cancer. University of Toronto Medical Journal. 88:182-189. 2011
- High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review. Clinical Oncology. 23:117-127. 2011
- Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies. International Journal of Oncology. 37:761-766. 2010
- High-intensity focused ultrasound for prostate cancer: a practice guideline. Journal of the Canadian Urological Association. 4:232-232. 2010
- Editorial Comment. Urology. 75:332-333. 2010
- Management of the urethra in urothelial bladder cancer. Journal of the Canadian Urological Association. 3:211-211. 2009
- Management of the urethra in urothelial bladder cancer. Journal of the Canadian Urological Association. 3:S211-S214. 2009
- Editorial Comment. Urology. 74:1074-1075. 2009
- Editorial Comment. Journal of Urology. 182:971-971. 2009
- Editorial Comment. Investigative Urology. 182:971-971. 2009
- Incidence of Metastatic Nonseminomatous Germ Cell Tumor Outside the Boundaries of a Modified Postchemotherapy Retroperitoneal Lymph Node Dissection. Journal of Clinical Oncology. 25:4365-4369. 2007
- Clinical outcome following post‐chemotherapy retroperitoneal lymph node dissection in men with intermediate‐ and poor‐risk nonseminomatous germ cell tumour. BJU International. 99:993-997. 2007
- The Anatomical and Pathological Characteristics of Irradiated Prostate Cancers May Influence the Oncological Efficacy of Salvage Ablative Therapies. Investigative Urology. 177:1324-1329. 2007
- Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma. Journal of Clinical Oncology. 25:1033-1037. 2007
- The Anterior Layer of Denonvilliers’ Fascia: A Common Misconception in the Laparoscopic Prostatectomy Literature. Investigative Urology. 177:521-525. 2007
- Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection. Investigative Urology. 176:100-104. 2006
- Prevalence of abnormal sperm DNA denaturation in fertile and infertile men. Urology. 60:1069-1072. 2002